The US Patent and Trademark Office (USPTO) has recently approved the third patent application submitted by the biotech company Tissue Repair (ASX: TRP), which focuses on developing wound-healing agents. This patent—titled “BIOLOGICAL POLYSACCHARIDE COMPOUND” ]—includes claims that extend to the Glucoprime® compound and its molecule, allowing for various applications. Glucoprime and its derivatives serve as
Read More
With the largest workforce of early childhood educators in the country, G8 Education (ASX: GEM) has long struggled to manage their wage bill while delivering maximum profit for shareholders. That looks to have changed in 2023 though, with the Company divesting unprofitable centres and streamlining their workforce, in lieu of occupancy growth. The Company announced
Read More
Medical diagnostics company Rhythm Biosciences (ASX: RHY) has undertaken a comprehensive strategic review following major shareholder discontent and a subsequent S249D notice requesting a vote to remove the Chairman. In October, the Company faced regulatory scrutiny as its stock value plunged from 32¢ to 20¢, triggering an ASX “speeding ticket”. Later, the stock was trading
Read More
Kitchen, wardrobe and other household products supplier Joyce Corporation (ASX: JYC) has announced the expansion of its bedding subsidiary, Bedshed, with the acquisition of two prime locations in suburban Sydney. The franchise agreements, finalised with two franchisees, will see Bedshed taking control of stores in Alexandria and Castle Hill. The move is part of Bedshed’s
Read More
For the past 12 months, MyState Bank (ASX: MYS) has been hot in the lending market as Australians seeking to refinance their mortgages to the lowest available rate have regularly landed at MyState which has consistently been more competitive than the Big Four banks. But with all of those new loans written, the Tasmanian-based MyState
Read More
As blockchain technology continues to disrupt traditional financial institutions, digital payments company Novatti Group (ASX: NOV) has secured a range of new investors keen for a slice of their AUDD stablecoin business which has minted more than $4 million since launching. AUDD is a 1:1 fiat-backed stablecoin that enables businesses, people and governments to make
Read More
Rest, one of Australia’s premier profit-to-member superannuation funds and a key ally of Link, has entered into a trial partnership with workplace compliance solutions provider Wrkr (ASX: WRK). The collaboration aims to test various innovative solutions that could reshape the landscape of superannuation administration. Rest manages about $75 billion in funds with nearly two million
Read More
Despite the challenges of COVID-19, Australia’s wealth management market saw a 3% rise, reaching $1.2 trillion in assets (excluding superannuation). Thanks to a resilient stock market, rising asset values, and increased savings, the future looks promising especially over the next five years, according to research by management consulting firm Oliver Wyman. Finance professionals are often
Read More
Biotech company Argenica Therapeutics Limited (ASX: AGN), which is developing novel therapeutics to reduce brain tissue death after stroke, has completed the production of its neuroprotective peptide candidate ARG-007 in powder form. The Company is gearing up for its Phase 2 clinical trials, and the final manufacturing of the sterile drug product in vials is
Read More
The largest police department in the United States is set to unveil a squadron of drones that will act as first responders to scenes across the city, powered by artificial intelligence and supplied by drone company Nightingale Intelligent Systems (ASX: NGL). The 3-year supply contract is with the unnamed Police Department but a simple Google
Read More
